MILLER STRATEGIES, LLC

Lobbying for BRISTOL-MYERS SQUIBB COMPANY · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · posted Jul 20, 2026

Lobbying activity 2

Health Issues

Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.

Medicare/Medicaid

Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.